EconomyLens.com
No Result
View All Result
Monday, November 16, 2026
  • Home
  • Economy
  • Business
  • Markets
  • Tech
  • Editorials
EconomyLens.com
  • Home
  • Economy
  • Business
  • Markets
  • Tech
  • Editorials
No Result
View All Result
EconomyLens.com
No Result
View All Result
Home Economy

UK drugmaker GSK posts mixed first-quarter earnings

David Peterson by David Peterson
May 1, 2024
in Economy
Reading Time: 3 mins read
A A
0
27
SHARES
341
VIEWS
Share on FacebookShare on Twitter

Lennie McCloskey, Constable of Manistee Justice Precint in Maricopa County watches as a family who has just been evicted carry out their belongings on April 15, 2024 in Phoenix, Arizona. ©AFP

London (AFP) – British drugmaker GlaxoSmithKline on Wednesday said its net profit sank in the first quarter on higher exceptional costs compared with a year earlier, but that underlying earnings jumped.

Related

Paraguay leader says retirees with accounts in collapsed bank to be paid this week

Africa should trade more with itself: Botswana president

Former Togo PM re-elected as UN labour agency chief

Belgian king gives PM more time to solve budget impasse

Carney says US tariffs could turn Canada’s carmakers to China

Profit after tax dropped 23 percent to £1.08 billion ($1.35 billion), GSK said in an earnings statement.

However core operating profit excluding exceptional items rallied 27 percent to £2.4 billion, while revenues swelled 10 percent to £7.4 billion.

GSK chief executive Emma Walmsley said the quarter saw further progress in final trials of new drugs.

“We have made a strong start to 2024, with another quarter of excellent performance and continued pipeline progress,” she said in the statement.

“We have strengthened prospects for growth in all of our key therapeutic areas this quarter: infectious diseases, HIV, respiratory/immunology and oncology.”

The group’s share price rose 2.3 percent in early afternoon trading on London’s top-tier FTSE 100 index, lifted by the upgraded full-year outlook.

“GSK has started 2024 in rude health. Strong growth in vaccine and speciality medicines drove a double digit rise in group sales,” said Derren Nathan, head of equity research at Hargreaves Lansdown.

The first quarter saw GSK agree to buy Aiolos Bio for up to $1.4 billion, with a focus on an asthma medication still at the testing stage.

© 2024 AFP

Tags: Earningsgskpharmaceuticals
Share11Tweet7Share2Pin2Send
Previous Post

Evictions surge in Arizona with housing shortage and rising prices

Next Post

Yen slips after rallying on suspected intervention, stocks mixed

David Peterson

David Peterson

Related Posts

Economy

US airports expected to return to normal after three days of disruption

November 16, 2026
Economy

Trump admin warns air travelers of another messy day

November 15, 2026
Economy

Trade war in focus at ASEAN summit ahead of Trump arrival

November 16, 2026
Economy

FAA chief says US air travel back to normal by Sunday

November 16, 2026
Economy

Hybrids make gains in US auto market amid high gasoline prices

November 15, 2026
Economy

UN official urges Iran, US to let fertilisers through Hormuz Strait

November 15, 2026
Next Post

Yen slips after rallying on suspected intervention, stocks mixed

Microsoft announces $2.2 bn AI, cloud investment in Malaysia

Shell logs sliding profits as revenues sink

French govt to 'fight' TotalEnergies New York listing

0 0 votes
Article Rating
Subscribe
Notify of
guest
guest
0 Comments
Oldest
Newest Most Voted
  • Trending
  • Comments
  • Latest

New York ruling deals Trump business a major blow

September 30, 2024

Elon Musk’s X fights Australian watchdog over church stabbing posts

April 21, 2024

Women journalists bear the brunt of cyberbullying

April 22, 2024

France probes TotalEnergies over 2021 Mozambique attack

May 6, 2024

New York ruling deals Trump business a major blow

104

Ghanaian finance ministry warns against fallout from anti-LGBTQ law

74

Shady bleaching jabs fuel health fears, scams in W. Africa

71

Stock markets waver, oil prices edge up

65

Tech shares slump ahead of Nvidia earnings, Anthropic IPO

November 16, 2026

‘It’s growing’: Jude Bellingham underwear ad shows soccer’s US appeal

November 16, 2026

Paraguay leader says retirees with accounts in collapsed bank to be paid this week

November 16, 2026

Nvidia faces earnings test amid calls for Huang comeback

November 16, 2026
From EconomyLens

Clear insights, straight to your inbox.

Get the stories and perspectives shaping the economy.

EconomyLens Logo

We bring the world economy to you. Get the latest news and insights on the global economy, from trade and finance to technology and innovation.

Your Privacy Choices

Pages

  • Home
  • About Us
  • Privacy Policy
  • Contact Us

Categories

  • Business
  • Economy
  • Markets
  • Tech
  • Editorials

Network

  • Coolinarco.com
  • CasualSelf.com
  • Fit.CasualSelf.com
  • Sport.CasualSelf.com
  • SportBeep.com
  • MachinaSphere.com
  • MagnifyPost.com
  • TodayAiNews.com
  • VideosArena.com
© 2026 EconomyLens.com - Top economic news from around the world.
No Result
View All Result
  • Home
  • Economy
  • Business
  • Markets
  • Tech
  • Editorials

© 2024 EconomyLens.com - Top economic news from around the world.